glp-1 weight loss drug news today 2025 The first issue of New Scientist for 2026 brings a sharp focus on to medications. It suggests that weight-loss medications should get cheaper and more accessible (with expiry of GLP-1 Agonists Weight Loss Drugs

Peptides can cause skin reactions with topical application, such as redness, inflammation, a rash or swelling [12]

SCA in which the intracellular concentration of HbS is almost 100%, is by far the most severe and well described ( The fundamental event that underlies the complex pathophysiology and multi-systemic consequences of SCD is the polymerization of HbS that occurs under low oxygen tension (Figure 2)

These outcomes not only improve patient health and quality of life but also increase physician confidence in prescribing GLP-1 therapies

Sermorelin BPC-157 and Sermorelin are both peptides often discussed in recovery, performance, and longevity contexts, but they differ significantly in mechanism, purpose, and evidence base